3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lung Neoplasms
22
Breast Neoplasms
18
Hematologic Neoplasms
17
Colorectal Neoplasms
13
Prostatic Neoplasms
11
Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pancreatic Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
8
Anatomic Stage I Breast Cancer AJCC v8
8
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Multiple Myeloma
5
Melanoma
5
Head and Neck Carcinoma
5
Breast Carcinoma In Situ
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Hematopoietic and Lymphoid System Neoplasm
4
Mouth Neoplasms
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Carcinoma
3
Interventions
Gemcitabine
8
pembrolizumab
5
Cisplatin
5
enfortumab vedotin
3
avelumab
3
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
vinflunine
2
Radiotherapy
2
Nephroureterectomy
2
Immunoglobulin G
2
Doxorubicin
2
Disulfides
2
vandetanib
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
pegfilgrastim
1
merphos
1
guadecitabine
1
genexol-PM
1
enzalutamide
1
durvalumab
1
dehydroftorafur
1
atezolizumab
1
abexinostat
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ureteral Neoplasms
×
Practice Guidelines as Topic
×
Clear all
NCT07087860
2026-05-08
RECIPE-B1
Mayo Clinic
Phase 2
Recruiting
70 enrolled